Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway. 2015

Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most lethal cancer worldwide. Evidence has shown HCC cell resistance to TRAIL‑mediated apoptosis. In a previous study, we verified that silencing SNAIL downregulated the growth of HCC cells. In addition, the mechanism of resistance to TRAIL in HCC cells was connected with the activation of nuclear factor-κB (NF-κB). Thus, it was hypothesized that the downregultaion of SNAIL sensitizes HCC cells to TRAIL-induced apoptosis by regulating the NF-κB pathway. In the present study, the most effective lentiviral vectors carrying shRNA against SNAIL were selected and adenoviral vectors harboring TRAIL were constructed. The expression of SNAIL and TRAIL was detected by quantitative PCR and western blotting. HCC cell viability and apoptosis were assessed using an MTT assay and the Hoechst test. To determine how to sensitize HCC cells to TRAIL-induced apoptosis after silencing SNAIL, p53 was assessed by western blot analysis. We also investigated the expression of Bcl-xL, cIAP2, survivin and Raf-1 protein using western blot analysis and the apoptotic degree of HuH-7 cells was detected using the Hoechst test following the suppression of each gene, which was a possible molecular mechanism to sensitive TRAIL-induced apoptosis through the downregulation of SNAIL in HCC cells. Silencing SNAIL resulted in increased apoptosis by enhancing sensitization to TRAIL in all the HCC cells. Additionally, p53 protein was upregulated in HuH-7 cells. Expression of Bcl-xL, cIAP2, survivin and Raf-1 was downregulated following silencing of SNAIL, while down-regulation of any of the proteins contributed to SNAIL suppression enhancing HCC cell sensitivity to TRAIL‑induced apoptosis, with the exception of cIAP2. The results demonstrated that silencing SNAIL can sensitize TRAIL-induced apoptosis in HCC cells by upregulating p53 protein and by regulating related genes of the NF-κB pathway such as Bcl-xL, survivin and Raf-1.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071250 Snail Family Transcription Factors A transcription factor family characterized by the presence of several C-terminal CYS2-HIS2 ZINC FINGERS. They function in many developmental processes including the induction of the EPITHELIAL-MESENCHYMAL TRANSITION; maintenance of embryonic MESODERM; growth arrest, CELL SURVIVAL; and CELL MIGRATION. Slug Transcription Factors,Snail Transcription Factors,Transcription Factors, Slug,Transcription Factors, Snail
D000075747 Baculoviral IAP Repeat-Containing 3 Protein A regulator of APOPTOSIS that functions as an E3 ubiquitin protein ligase. It contains three baculoviral IAP repeats in its N-terminal half, a CARD DOMAIN, and a RING finger domain at its C-terminus. It is highly expressed in fetal lung and kidney, and adult lymphoid tissues such as spleen, thymus, and peripheral blood lymphocytes. It functions in INFLAMMATION signaling, the INNATE IMMUNE RESPONSE, cell growth and proliferation, and metastasis of tumor cells. Apoptosis Inhibitor 2,BIRC3 Protein,Baculoviral IAP Repeat Containing Protein 3,Cellular Inhibitor of Apoptosis-2,Hiap-1 Protein,IAP1 Protein,Inhibitor of Apoptosis 1 Protein,Inhibitor of Apoptosis Protein 1,c-IAP2 Protein,cIAP2 Protein,Apoptosis-2 Cellular Inhibitor,Baculoviral IAP Repeat Containing 3 Protein,Cellular Inhibitor of Apoptosis 2,Hiap 1 Protein,Inhibitor 2, Apoptosis
D000077022 Survivin An apoptosis inhibitory protein that contains a single baculoviral IAP repeat (BIR) domain. It associates with MICROTUBULES and functions to regulate cell proliferation as a component of the chromosome passage protein complex (CPC), performing essential roles for localization of the complex, chromosome alignment, segregation during MITOSIS and CYTOKINESIS, and assembly of the MITOTIC SPINDLE. It is expressed by fetal kidney and liver cells and highly expressed in ADENOCARCINOMA and high-grade LYMPHOMA. BIRC5 Protein,Baculoviral IAP Repeat-containing Protein 5,Baculoviral IAP Repeat containing Protein 5
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
January 2017, OncoTargets and therapy,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
January 2017, Neoplasma,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
February 2019, Oncology letters,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
January 2012, Biomolecules & therapeutics,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
August 2006, Oncology reports,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
June 2009, International journal of cancer,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
January 2021, Frontiers in pharmacology,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
June 2018, Biochemical and biophysical research communications,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
January 2017, Oncology research,
Zhaojun Wan, and Huazheng Pan, and Shihai Liu, and Jingjuan Zhu, and Weiwei Qi, and Kai Fu, and Teng Zhao, and Jun Liang
June 2017, Oncology letters,
Copied contents to your clipboard!